Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers.
Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers.
复制标题
DOI：
10.3390/ijms23041926
复制
发表时间：
2022-02-09
影响因子：
5.6
通讯作者：
Duda DG
中科院分区：
文献类型：
--
作者：
Hauth F;Roberts HJ;Hong TS;Duda DG
While the incidence of primary liver cancers has been increasing worldwide over the last few decades, the mortality has remained consistently high. Most patients present with underlying liver disease and have limited treatment options. In recent years, radiotherapy has emerged as a promising approach for some patients; however, the risk of radiation induced liver disease (RILD) remains a limiting factor for some patients. Thus, the discovery and validation of biomarkers to measure treatment response and toxicity is critical to make progress in personalizing radiotherapy for liver cancers. While tissue biomarkers are optimal, hepatocellular carcinoma (HCC) is typically diagnosed radiographically, making tumor tissue not readily available. Alternatively, blood-based diagnostics may be a more practical option as blood draws are minimally invasive, widely availability and may be performed serially during treatment. Possible blood-based diagnostics include indocyanine green test, plasma or serum levels of HGF or cytokines, circulating blood cells and genomic biomarkers. The albumin–bilirubin (ALBI) score incorporates albumin and bilirubin to subdivide patients with well-compensated underlying liver dysfunction (Child–Pugh score A) into two distinct groups. This review provides an overview of the current knowledge on circulating biomarkers and blood-based scores in patients with malignant liver disease undergoing radiotherapy and outlines potential future directions.
登录
查看更多内容
影响因子：
4.3
作者：
Cha H;Lee EJ;Seong J
通讯作者：
Seong J
影响因子：
3.4
作者：
Fu, Rongdang;Jiang, Shaotao;Zhang, Xiaohong
通讯作者：
Zhang, Xiaohong
影响因子：
--
作者：
Finkelstein SE;Timmerman R;McBride WH;Schaue D;Hoffe SE;Mantz CA;Wilson GD
通讯作者：
Wilson GD
DOI：
10.1016/j.ijrobp.2018.04.026
发表时间：
2018-08-01
期刊：
International journal of radiation oncology, biology, physics
影响因子：
--
作者：
Grassberger C;Hong TS;Hato T;Yeap BY;Wo JY;Tracy M;Bortfeld T;Wolfgang JA;Eyler CE;Goyal L;Clark JW;Crane CH;Koay EJ;Cobbold M;DeLaney TF;Jain RK;Zhu AX;Duda DG
通讯作者：
Duda DG
影响因子：
4.1
作者：
De B;Ng SP;Liu AY;Avila S;Tao R;Holliday EB;Brownlee Z;Kaseb A;Lee S;Raghav K;Vauthey JN;Minsky BD;Herman JM;Das P;Smith GL;Taniguchi CM;Krishnan S;Crane CH;Grassberger C;Hong TS;Lin SH;Koong AC;Mohan R;Koay EJ
通讯作者：
Koay EJ